Chad Mineo: Platelet-Rich Plasma as an Adjunct to Rehabilitation in Grade 2 Hamstring Injuries
Chad Mineo, Physician Extender and Research Coordinator at Columbia University Irving Medical Center, shared a post on LinkedIn about a recent article by Clevio Desouza et al, adding:
“Platelet Rich Plasma (PRP) for Hamstrings:
High-quality ultrasound plus high-quality intervention equals better outcomes.
PRP hasn’t consistently beaten rehab for hamstring injuries—but context matters.
A 2025 RCT in European Journal of Orthopaedic Surgery and Traumatology showed:
US-guided PRP plus rehab equals faster RTP (approximately 26 versus approximately 34 days) plus improved early healing
Compare that to the negative British Journal of Sports Medicine (2015) trial:
- No imaging guidance
- Questionable PRP prep
- Broad patient selection
Not all PRP, or studies, are created equal.
Approach for grade 2 hamstrings:
- Rehab is the foundation (objective RTP criteria)
- PRP equals adjunct with uncertain upside
- Only if done right (image guidance, true PRP, structured rehab)
- Expect modest gains (days, not reinjury prevention)
Bottom line: PRP isn’t a magic bullet—but in the right hands, it may provide an edge.”
Title: Efficacy of platelet-rich plasma in grade 2 hamstring muscle injuries: results from a randomized controlled trial
Authors: Clevio Desouza, Vijay Shetty
Read the Full Article on Springer Nature.

Stay updated on all scientific advances with Hemostasis Today.
-
Aug 21, 2026, 14:32Kenneth Nollet: Building the Future of Transfusion Laboratory Science
-
Aug 21, 2026, 14:14Tareq Abadl: A Positive Antibody Screen is Not The Diagnosis
-
Aug 21, 2026, 14:08Katrina Snow։ Transfusion Trends and Quality Improvement in Sickle Cell Disease
-
Aug 21, 2026, 14:00Rucha Patil: The Power of Point-of-Care Testing in Hemostasis
-
Aug 21, 2026, 13:56Sarah Kowalski։ Supporting the Next Generation of Transfusion Laboratory Scientists
-
Aug 21, 2026, 13:51Join EHC 2026 Annual Conference
-
Aug 21, 2026, 12:57David McIntosh: Why Do Blood Supplies Still Fall Short?
-
Aug 21, 2026, 12:48Joshua Penrod: 35 Years of Progress in Plasma Safety
-
Aug 21, 2026, 12:42Moustafa Abdou: Diagnosis and Management of Pyruvate Kinase Deficiency